Cellectis bioresearch (Paris, France) provides life science researchers with ready- and easy-to-use tools for genome customization.
These tools, based on sequence-specific nucleases, enable the engineering of cells with optimized features for drug discovery, protein production and gene functional studies.
The company exclusively offers Custom TALEN™ services for the production of the next generation gene customization tools. TALEN™ are sequence-specific nucleases enabling gene knock-out or modification of any gene, at any position, in any genome.
Cellectis bioresearch also provides ready-to-use cGPS® Targeted Integration Kits for the rapid and effortless generation of stable and isogenic cell lines.